$APP

Why is AppLovin stock sliding today?

AppLovin shares fell about 1.5% in pre-open trading to $333.84, near the 52-week low of $332.19. The company reported Q2 2026 revenue of $1.92B versus about $1.95B expected, and Q3 guidance midpoint around $2.075B, slightly below consensus. Multiple analysts cut targets and some downgraded after the earnings miss.

Original reporting
Published Aug 11, 2026, 10:21 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 10:44 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$APP
Bearish
medium confidence
Mentioned
$APP
Relevance
8/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$APPBearishMed
01

Why it matters

APP’s pre-open decline is linked to a Q2 revenue miss versus consensus and Q3 guidance that is marginally below expectations, followed by multiple analyst target reductions citing muted growth, AXON timing, and higher compute/inference costs.

02

Market read

Company-specific earnings and guidance details are the driver, with analysts cutting targets and no immediate macro offset until CPI tomorrow.

03

What to watch

The article highlights compute and inference costs tied to model training and AXON timing mismatches, but does not quantify whether these are temporary or structural, leaving room for a rebound if subsequent updates clarify cost trajectory.

Relevance 8/10Novelty 6/10Timing: pre-open today, with CPI scheduled for tomorrow but no fresh macro catalyst today

Background

The piece frames the move as AppLovin’s first meaningful earnings disappointment since going public, with investors also awaiting tomorrow’s July 2026 CPI release.

Company-level read

Ticker impact

$APPBearishMedium confidence
Context

AppLovin shares slid 1.5% pre-open after Q2 revenue missed consensus and Q3 guidance midpoint came in below expectations.

Expected impact

Near-term downside pressure likely persists while investors digest execution risk around AXON model improvements and gaming ad growth.

Evidence & confidence

It cites specific Q2 revenue and Q3 guidance numbers, plus a “flurry” of target cuts (Wells Fargo, Piper Sandler, Goldman, Scotiabank, BofA, Phillip), which typically sustains bearish positioning into the next sessions.

Market effects

Weakness in a mobile ad-tech name may pressure sentiment across digital advertising and mobile technology peers, especially around ad growth and compute cost concerns.

Primarily US-focused via pre-open trading and US earnings/guidance digestion; limited spillover described beyond broad index neutrality.

No direct global macro or cross-border catalyst is described; impact is mainly company-specific.

Counterpoint

Despite downgrades, several banks maintained buy-equivalent ratings, implying the selloff may be more about timing and near-term execution than long-term demand.

Key entities

  • AppLovin

    Subject of the article; stock is down pre-open after Q2 revenue miss and slightly light Q3 guidance.

  • Wells Fargo

    Downgraded the stock outright per the article.

  • Piper Sandler

    Downgraded the stock outright per the article.

  • Goldman Sachs

    Revised its target lower to $465, citing muted near-term growth and AXON timing mismatches.

Related articles

$APPMed

Why AppLovin Stock Slumped by 6% Today

AppLovin shares (APP) fell about 6% after its disappointing Q2 earnings results and an analyst downgrade. Bank of America Securities’ Omar Dessouky cut his rating from buy to neutral and lowered the price target to $400 from $430, citing concerns about meeting a 30% long-term revenue growth goal and the durability of AI-driven efficiency gains.

$JBLMed

Stocks making the biggest moves midday: Jabil, AppLovin, Apollo, SpaceX, Upwork & more

Midday movers included Jabil, up 5% after a UBS upgrade to Buy, and AppLovin, down 5% after Bank of America downgraded to neutral and cut its price target to $400. Aramark rose 9% after Q3 beat and raised forecast. Under Armour fell 8% on a Barclays downgrade. Upwork dropped 13% on weaker guidance. Fermi jumped 22% after a first binding lease with TensorWave for 222 MW and about $6.5B contracted revenue.

$APPMed

AppLovin shares drop on Bank of America downgrade

Bank of America downgraded AppLovin (APP) to Neutral, saying recent results raise uncertainty about sustaining its long-term 30% revenue growth target. It questioned whether self-learning drives sequential growth and said larger recommender models need more evidence. BofA cut its 2027 revenue growth to 23% and EBITDA to $8.3B, lowered the 2027 consumer forecast, and reduced its price target to $400 from $430.

$APPMed

AppLovin Revenue Jumped 53%. So Why Did the Stock Just Plunge 20%?

AppLovin reported Q2 revenue of $1.92B, up 53% but slightly below the $1.94B analyst consensus, citing slower AI model improvement. Adjusted EPS rose 57% to $3.76 and adjusted EBITDA rose 58% to $1.6B. Free cash flow was $863.3M in Q2. Q3 revenue guidance was $2.055B-$2.085B. The stock fell about 20% after the results.